Swiss pharma giant Roche to invest $50 billion in US amid growing tariff uncertainty
Roche, a Swiss pharmaceutical giant, will invest $50 billion in the United States over the next five years, creating 12,000 jobs and expanding manufacturing, distribution, and research. This decision, following a similar move by Novartis, aims to strengthen Roche's US footprint and support innovation in medicines and diagnostics.
Roche, a Swiss pharmaceutical giant, will invest $50 billion in the United States over the next five years, creating 12,000 jobs and expanding manufacturing, distribution, and research. This decision, following a similar move by Novartis, aims to strengthen Roche's US footprint and support innovation in medicines and diagnostics.
